Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Reducing residual cardiovascular risk with novel therapies.
GENES RESPONSIBLE IN INSULIN-DEPENDENT DIABETES MELLITUS
To a New Normal: Surgery and COVID-19 during the Transition Phase.
Systems biology of the human microbiome.
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
See All 12 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib. Sci Rep. 2018 01 17; 8(1):948.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Cell Cycle Proteins
Cell Line, Tumor
Humans
Lung Neoplasms
Mutation
Niacinamide
Nuclear Proteins
Phenylurea Compounds
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Proto-Oncogene Proteins p21(ras)
Pyrazoles
Pyrimidines
Pyrimidinones
authors with profiles
Marina Chiara Garassino